|
COST
|
Consumer Defensive |
Wells Fargo |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$486.8B
|
$296.97
|
+0.8%
|
+2.3%
|
-1.6%
|
-0.7%
|
-2.1%
|
-0.3%
|
|
COST
|
Consumer Defensive |
Baird |
Maintains
|
Outperform
→
Outperform
|
—
|
$486.8B
|
$296.97
|
+0.8%
|
+2.3%
|
-1.6%
|
-0.7%
|
-2.1%
|
-0.3%
|
|
COST
|
Consumer Defensive |
Stifel |
Maintains
|
Buy
→
Buy
|
—
|
$486.8B
|
$296.97
|
+0.8%
|
+2.3%
|
-1.6%
|
-0.7%
|
-2.1%
|
-0.3%
|
|
BAC
|
Financial Services |
Keefe Bruyette & Woods |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$386.6B
|
$28.12
|
-0.4%
|
-1.4%
|
+3.2%
|
+2.5%
|
+0.4%
|
+0.7%
|
|
BAC
|
Financial Services |
Keefe, Bruyette & Woods |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$386.6B
|
$28.12
|
-0.4%
|
-1.4%
|
+3.2%
|
+2.5%
|
+0.4%
|
+0.7%
|
|
BABA
|
Consumer Cyclical |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$178.94
|
+0.0%
|
-1.3%
|
+0.6%
|
-1.6%
|
+0.6%
|
+1.2%
|
|
PEP
|
Consumer Defensive |
Credit Suisse |
Maintains
|
Underperform
→
Underperform
|
—
|
$206.5B
|
$135.98
|
+0.7%
|
+1.0%
|
-0.7%
|
-0.4%
|
+0.4%
|
+0.7%
|
|
NEE
|
Utilities |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$188.1B
|
$54.95
|
+0.1%
|
+0.2%
|
-0.1%
|
-0.8%
|
+0.9%
|
+0.3%
|
|
WDC
|
Technology |
Benchmark |
Maintains
|
Sell
→
Sell
|
—
|
$163.6B
|
$46.81
|
+0.2%
|
+0.5%
|
+0.8%
|
-0.8%
|
+3.3%
|
+0.6%
|
|
CRWD
|
Technology |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$159.2B
|
$86.85
|
-8.2%
|
-12.5%
|
-11.7%
|
+6.8%
|
-3.5%
|
+0.8%
|
|
VRTX
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$112.1B
|
$179.86
|
+0.3%
|
+0.8%
|
-3.6%
|
-2.2%
|
+1.2%
|
-0.4%
|
|
SO
|
Utilities |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$104.4B
|
$59.50
|
+0.4%
|
+0.3%
|
-1.1%
|
+0.3%
|
+0.9%
|
+0.5%
|
|
CNQ
|
Energy |
Wells Fargo |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$103.7B
|
$12.16
|
-1.4%
|
-1.6%
|
+3.4%
|
+3.8%
|
-1.0%
|
-0.2%
|
|
MAR
|
Consumer Cyclical |
JP Morgan |
Maintains
|
Neutral
→
Neutral
|
—
|
$96.6B
|
$128.46
|
+0.0%
|
+0.8%
|
+0.4%
|
+1.4%
|
+1.1%
|
-0.4%
|
|
HCA
|
Healthcare |
BofA SecuritiesA |
Upgrade
|
Underperform
→
Neutral
|
—
|
$93.4B
|
$124.25
|
+1.5%
|
+1.5%
|
+1.1%
|
+2.0%
|
+0.9%
|
-2.0%
|
|
CIEN
|
Technology |
B. Riley Securities |
Maintains
|
Buy
→
Buy
|
—
|
$78.7B
|
$39.62
|
+0.3%
|
-0.3%
|
-1.5%
|
+1.9%
|
+2.0%
|
-2.2%
|
|
CIEN
|
Technology |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$78.7B
|
$39.62
|
+0.3%
|
-0.3%
|
-1.5%
|
+1.9%
|
+2.0%
|
-2.2%
|
|
CIEN
|
Technology |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$78.7B
|
$39.62
|
+0.3%
|
-0.3%
|
-1.5%
|
+1.9%
|
+2.0%
|
-2.2%
|
|
CIEN
|
Technology |
B. Riley |
Maintains
|
Buy
→
Buy
|
—
|
$78.7B
|
$39.62
|
+0.3%
|
-0.3%
|
-1.5%
|
+1.9%
|
+2.0%
|
-2.2%
|
|
CIEN
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$78.7B
|
$39.62
|
+0.3%
|
-0.3%
|
-1.5%
|
+1.9%
|
+2.0%
|
-2.2%
|